{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:56:18Z","timestamp":1781556978041,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,4]],"date-time":"2027-05-04T00:00:00Z","timestamp":1809388800000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120758","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:38:06Z","timestamp":1777214286000},"page":"120758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program"],"prefix":"10.1016","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2528-4624","authenticated-orcid":false,"given":"Yixin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Quynh H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sevilla-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Haessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Sarnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsu-Zsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yii-Der","family":"Ida Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"DiCorpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Durda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark O.","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Heard-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Craig","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome I.","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa K.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0703-0742","authenticated-orcid":false,"given":"Ching-Ti","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120758_bib1","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120758_bib2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archinte.164.13.1422","article-title":"The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up","volume":"164","author":"Almdal","year":"2004","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ecl.2017.10.010","article-title":"Pathogenesis of cardiovascular disease in diabetes","volume":"47","author":"Haas","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120758_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/metabo12040357","article-title":"Guide to metabolomics analysis: a bioinformatics workflow","volume":"12","author":"Chen","year":"2022","journal-title":"Metabolites"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120758_bib6","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120758_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40200-023-01256-8","article-title":"Metabolomics signature of cardiovascular disease in patients with diabetes, a narrative review","volume":"22","author":"Dodangeh","year":"2023","journal-title":"J Diabetes Metab Disord"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120758_bib8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dc07-0019","article-title":"Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes","volume":"30","author":"Krzyzanowska","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7938216","article-title":"Metabolomic signature of coronary artery disease in type 2 diabetes mellitus","volume":"2017","author":"Stratmann","year":"2017","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.talanta.2015.10.070","article-title":"Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: a pilot study","volume":"148","author":"Garc\u00eda-Fontana","year":"2016","journal-title":"Talanta"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120758_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurjpc\/zwad160","article-title":"Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes","volume":"30","author":"Huang","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-019-0851-z","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies","volume":"18","author":"Ye","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"7845","key":"10.1016\/j.atherosclerosis.2026.120758_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"9921","key":"10.1016\/j.atherosclerosis.2026.120758_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120758_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the women\u2019s health initiative clinical trial and observational study","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120758_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The atherosclerosis risk in communities (ARIC) study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120758_bib19","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (atherosclerosis risk in communities) study: JACC Focus Seminar 3\/8","volume":"77","author":"Wright","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120758_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/STROKEAHA.120.031792","article-title":"Whole-genome sequencing association analyses of stroke and its subtypes in ancestrally diverse populations from trans-omics for precision medicine project","volume":"53","author":"Hu","year":"2022","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120758_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ng.3913","article-title":"Association analyses based on false discovery rate implicate new loci for coronary artery disease","volume":"49","author":"Nelson","year":"2017","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120758_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","article-title":"Metabolic predictors of incident coronary heart disease in women","volume":"137","author":"Paynter","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120758_bib23","doi-asserted-by":"crossref","first-page":"btaf290","DOI":"10.1093\/bioinformatics\/btaf290","article-title":"Eclipse: a python package for alignment of two or more nontargeted LC-MS metabolomics datasets","volume":"41","author":"Hitchcock","year":"2025","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120758_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010896","article-title":"Metabolomic association and risk prediction with heart failure in older adults","volume":"17","author":"Liu","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120758_bib25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.amjcard.2019.03.017","article-title":"Serum metabolomics and incidence of atrial fibrillation (from the atherosclerosis risk in communities study)","volume":"123","author":"Alonso","year":"2019","journal-title":"Am J Cardiol"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2026.120758_bib26","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the Human Metabolome Database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120758_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.104444","article-title":"Metabolomic profile alterations associated with the SLC16A11 risk haplotype following a lifestyle intervention in people with prediabetes","volume":"8","author":"Sevilla-Gonz\u00e1lez","year":"2024","journal-title":"Curr Dev Nutr"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","article-title":"Missing value imputation approach for mass spectrometry-based metabolomics data","volume":"8","author":"Wei","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12920-020-00838-2","article-title":"Genome-wide transcriptome study using deep RNA sequencing for myocardial infarction and coronary artery calcification","volume":"14","author":"Zhang","year":"2021","journal-title":"BMC Med Genom"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","article-title":"Redefine statistical significance","volume":"2","author":"Benjamin","year":"2018","journal-title":"Nat Hum Behav"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120758_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009105","article-title":"Pathway analysis in metabolomics: recommendations for the use of over-representation analysis","volume":"17","author":"Wieder","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"W1","key":"10.1016\/j.atherosclerosis.2026.120758_bib32","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issue","key":"10.1016\/j.atherosclerosis.2026.120758_bib33","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkq329","article-title":"MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data","volume":"38","author":"Xia","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s42003-024-06680-x","article-title":"Multi-omics insight into the metabolic and cellular characteristics in the pathogenesis of hypothyroidism","volume":"7","author":"Zheng","year":"2024","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120758_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ng.120","article-title":"Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes","volume":"40","author":"Zeggini","year":"2008","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120758_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","article-title":"Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix","volume":"95","author":"Li","year":"2005","journal-title":"Heredity"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120758_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.115.018713","article-title":"Epidemiology and mechanisms of uremia-related cardiovascular disease","volume":"133","author":"Tonelli","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2070926","article-title":"Gestational diabetes mellitus and future cardiovascular risk: an update","volume":"2016","author":"Burlina","year":"2016","journal-title":"Int J Endocrinol"},{"issue":"9 Pt B","key":"10.1016\/j.atherosclerosis.2026.120758_bib39","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"Van Der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9154295","article-title":"Biomarkers of oxidative stress tethered to cardiovascular diseases","volume":"2022","author":"Panda","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"10 Suppl","key":"10.1016\/j.atherosclerosis.2026.120758_bib41","doi-asserted-by":"crossref","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cL-Arginine Paradox\u201d and acts as a novel cardiovascular risk factor","volume":"134","author":"B\u00f6ger","year":"2004","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120758_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"ATVB"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2005.12.007","article-title":"Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes","volume":"189","author":"Krzyzanowska","year":"2006","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120758_bib44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2337\/dc07-1762","article-title":"Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"31","author":"Lajer","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120758_bib45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12933-025-02981-5","article-title":"Plasma metabolomics disentangles T2DM- and CAD-Specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patients","volume":"24","author":"Hu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120758_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12975-020-00862-5","article-title":"Uric acid and gluconic acid as predictors of hyperglycemia and cytotoxic injury after stroke","volume":"12","author":"Ament","year":"2021","journal-title":"Transl Stroke Res"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120758_bib47","doi-asserted-by":"crossref","first-page":"e2312","DOI":"10.1212\/WNL.0000000000207264","article-title":"Association of circulating metabolites with racial disparities in hypertension and stroke in the REGARDS study","volume":"100","author":"Kijpaisalratana","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1074285","article-title":"Salivary metabolic signatures of carotid atherosclerosis in patients with type 2 diabetes hospitalized for treatment","volume":"9","author":"Sakanaka","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120758_bib49","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/antiox12081569","article-title":"A systematic review and meta-analysis of the association between uric acid and allantoin and rheumatoid arthritis","volume":"12","author":"Zinellu","year":"2023","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120758_bib50","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187543","article-title":"Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis","volume":"51","author":"Santana","year":"2018","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120758_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00015385.2017.1335104","article-title":"Serum allantoin and aminothiols as biomarkers of chronic heart failure","volume":"72","author":"Causs\u00e9","year":"2017","journal-title":"Acta Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120758_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2143\/AC.61.4.2017305","article-title":"Increased plasma homocysteine and allantoin levels in coronary artery disease","volume":"61","author":"\u00d6zkan","year":"2006","journal-title":"Acta Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120758_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251400724","article-title":"Identification of plasma phosphatidylethanolamine species associated with myocardial infarction risk in patients with stable angina: a cross-sectional lipidomics study","volume":"53","author":"Xue","year":"2025","journal-title":"J Int Med Res"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102281","article-title":"Regulation of HDL dysfunctionality by phosphatidylethanolamine links poly-unsaturated fatty acids with atherosclerotic cardiovascular diseases","volume":"103","author":"Taradeh","year":"2026","journal-title":"Mol Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120758_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1148410","article-title":"Phosphatidylethanolamine aggravates angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120758_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026885","article-title":"Large\u2010scale metabolomics and the incidence of cardiovascular disease","volume":"12","author":"Lind","year":"2023","journal-title":"JAHA"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:26:23Z","timestamp":1781555183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S0021915026001243"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120758","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120758"}}